Introduction
============

Dendritic cells (DCs) are myeloid or plasmacytoid phagocytes and have a key role in both the maintenance of T cell tolerance and the initiation and regulation of adaptive immune responses.[@R1] These functions require DC maturation by direct (pathogen-mediated) or indirect (cytokine-mediated) pathways. Maturation results in migration of DCs to defined lymphoid tissues and upregulation of major histocompatibility complex II (MHC II) and co-stimulatory molecules to optimize their antigen presentation capacity[@R2] ([Fig. 1](#F1){ref-type="fig"}). These important properties also contribute to adaptive immune responses, allowing DCs to serve as a major link between innate and adaptive immunity.[@R3] By the use of murine models and infection with *Salmonella enterica*, researchers try to unravel the mechanisms of host immune responses required for the resistance against systemic infections.[@R4]

![**Figure 1.** The role of dendritic cells (DCs) during bacterial infection in the mucosa. (**A**) Once microbes have overcome the intestinal barrier, they encounter DCs in underlying tissue or the Peyer's patches (PP) at the site of infection. (**B**) Upon phagocytic internalization of bacteria, DC maturation is initiated, which is crucial for the initiation of immunity. During this maturation, DCs lose phagocytic properties, but surface expression of MHC class II is upregulated, concomitant with the ability to present antigens. At the same time, lysosomal compartments fuse with the pathogen-containing phagosome to ensure bacterial degradation into peptide antigens. (**C**) Peptide antigens derived from degraded microbial proteins are loaded on MHC II complexes, transported to the cell surface and displayed. (**D**) During maturation DCs migrate from peripheral locations at the intestine to mesenteric lymph nodes (MLN). Here, they present the antigens to CD4-expressing T cells to initiate adaptive immune responses.](viru-3-660-g1){#F1}

*Salmonella enterica* is a major cause of bacterial food-borne infections with the ability to cause a variety of diseases in a range of hosts. The various *S. enterica* serovars remarkably differ with regard to their host range and degree of host adaptation.[@R5]*S. enterica* serovar (ser) Typhi (*S*. Typhi) is the causative agent of the systemic infection typhoid fever, and has shown to be specific for humans and primates since it fails to cause a systemic disease in mice and most other species.[@R6] On the other hand, serovars such as Enteritidis or Typhimurium result in infections as gastroenteritis with milder disease outcome, and also show broader host specificity, including humans, livestock animals, and various wild animals.[@R7] Susceptible mouse strains infected with *S.* Typhimurium are mainly used to investigate host immunity against *S.* Typhi, since systemic infections are induced with characteristics of human typhoid fever.

Salmonella is a facultative intracellular pathogen and proliferates within eukaryotic host cells, where the bacteria reside in a specialized compartment, named the Salmonella-containing vacuole (SCV) (reviewed in refs. [@R7], [@R8] and [@R9]). The capability of Salmonella to survive and eventually replicate intracellular is a key virulence trait and essential for its ability to cause systemic infection (reviewed in ref. [@R10]). The pathogenesis of diseases caused by Salmonella depends on the coordinated function of various sets of virulence proteins encoded by so-called Salmonella pathogenicity islands (SPI). Salmonella pathogenicity island 1 (SPI1) and Salmonella pathogenicity island 2 (SPI2) each encode a complex protein translocation machinery, termed type III secretion system (T3SS). By the delivery of sets of effector proteins into the host cell, the SPI1-T3SS and SPI2-T3SS are essential for the invasion of non-phagocytic cells, and for the establishment and continued modification of the intracellular niche, respectively (reviewed in ref. [@R10]). Additionally, effector proteins of T3SS can interfere with DC functions and have the capacity to prevent activation of adaptive immune responses to ensure bacterial survival in the intracellular space and the ability to cause systemic infection.

The intracellular activities of Salmonella in macrophages have been studied in detail, leading to the identification of several virulence factors essential for intracellular survival and proliferation in macrophages. However, only limited knowledge has been obtained concerning the activities of this intracellular pathogen within DCs. This review focuses on the interface between Salmonella and DCs: the initial interaction, bacterial internalization, intracellular activities and manipulation and evasion of DC-mediated immune responses. Additionally, questions that remained open so far will be addressed.

Virulence Factors of *Salmonella enterica*
==========================================

Host cell entry
---------------

Salmonella is a facultative intracellular organism with the ability to survive and grow in the extracellular environment as well as inside a host cell. It can thrive inside a variety of professional and non-professional phagocytes, including macrophages, DCs, neutrophils, M cells and enterocytes.[@R8] The bacterium is able to induce a unique form of phagocytosis in non-phagocytic cells, like epithelial cells, through action of SPI1-T3SS. Initiation of diverse host signal transduction cascades leads to membrane ruffling and subsequently "triggers" internalization of Salmonella by the host cell. These events are regulated by a subset of SPI1-T3SS effectors (SipA, SipC, SopB, SopD, SopE and SopE2) that induce extensive rearrangements of both the plasma membrane and the underlying actin cytoskeleton, resulting in the formation of macropinosomes.[@R11] The more conventional route of uptake via phagocytosis does not need an active contribution of the bacteria. "Professional" phagocytes, such as macrophages and DCs possess various receptors that enable them to recognize the pathogen and trigger phagocytic uptake. SPI1-T3SS-mediated invasion of phagocytes is also possible, but this entry leads to a rapid form of apoptotic cell death, termed pyroptosis.[@R12] Invasion-induced cell death was also reported for murine DCs.[@R13]

Intracellular life
------------------

Internalization by various host cells is followed by the intracellular phase of Salmonella pathogenesis. Despite of the host's anti-microbial activities, Salmonella has developed the capability to survive inside host cells, and this trait is essential for the ability to cause systemic infections. The bacteria reside in the SCV and here the action of the SPI2-T3SS plays an important role in the evasion of host immune defenses through the delivery of a second set of effector proteins from the SCV into the host cell cytoplasm.[@R7]^,^[@R14] Using these effector proteins, Salmonella actively directs the biogenesis of the SCV in order to segregate from the endosomal system, avoiding phagosome-lysosome fusion and degradation.[@R9]^,^[@R15]^,^[@R16] However, early reports suggest that Salmonella can survive within macrophages even after lysosomal compartments have fused with the SCV,[@R17]^,^[@R18] and indicate that avoidance of phagolysosomal fusion is unlikely to be a major pathogenic strategy of Salmonella. Moreover, SPI2 function was found to allow Salmonella to survive exposure to lysosomal contents by inhibiting the delivery of reactive oxygen species (ROS) and reactive nitrogen species (RNS) generating activities to the SCV.[@R19]^-^[@R21] Thereby Salmonella is able to avoid ROS- and RNS-dependent killing.

The SCV is maintained throughout intracellular life. During this lifetime, the SCV undergoes rapid modifications. The inchoate/early SCV is enriched in early endosome membrane markers, like EEA1, Rab5 and transferrin receptor,[@R22] whereas in the intermediate stage, these markers are replaced with late endosomal/lysosomal markers, including vacuolar H^+^ ATPase (vATPase) and lysosomal membrane glycoproteins (lgp) such as LAMPs. The transition between the early and the intermediate stage is accompanied by a decrease in the luminal pH to \< 4.5, due to the activity of the vATPase.[@R15] The late stage and the intermediate stage can be distinguished by the formation of the characteristic, lgp-rich membrane tubules, termed Salmonella-induced filaments (SIF), emanating from the SCV and extended throughout the cell (reviewed in ref. [@R23]). Recent work identified further Salmonella-induced tubular membrane compartments of distinct cellular origin.[@R23] Smith et al.[@R22] have shown that two independent, concurrent pathways, regulated by Syntaxin13 and Rab11, regulate recycling of cell surface proteins from the SCV. Interaction with these pathways is essential for efficient maturation of the SCV.

Although Salmonella mostly resides within the "safe" vacuole, a low percentage of wild-type *S.* Typhimurium succeeds to escape from the SCV shortly after invasion.[@R24]^-^[@R26] The SPI1- T3SS is found to be responsible for damaging the SCV shortly following invasion and although a repair mechanism was proposed where calcium is released and lysosomes are recruited,[@R27] a small proportion of Salmonella is able to escape into the cytosol.

Cytosolic bacteria are recognized by the autophagy machinery. Here, the intracellular pathogen is selectively sequestered in compartments that enrich the autophagosome-specific membrane marker LC3 (review in ref. [@R28]). Fusion of LC3-rich phagosomes with lysosomes is associated with a rapid acidification of the phagosomes, mainly mediated by the vacuolar vATPase.[@R29] Lysosomal proteases, which reach optimal proteolytic activity at a pH between 5.5 and 6.5, subsequently degrade the pathogen.[@R30]

Birmingham et al.[@R31] demonstrated that autophagy restricts bacterial growth in the cytosol by targeting Salmonella in damaged SCVs during infection. In addition, Wild et al.[@R32] found that upon phosphorylation of the autophagy receptor optineurin, autophagy clearance of cytosolic Salmonella is promoted. This reveals a role for the autophagy machinery in the host immune responses against Salmonella.

Routes of Infection by Salmonella
=================================

Penetration of intestinal barriers
----------------------------------

Several different routes are known for Salmonella to cross the intestinal barrier ([Fig. 2](#F2){ref-type="fig"}). Salmonella is an invasive pathogen and the SPI1-T3SS triggers the uptake by non-phagocytic enterocytes. While the role of the SPI1-T3SS and its effector proteins in invasion have been impressively demonstrated by cell culture models, the role of enterocyte invasion during infection of host organisms is less clear. First, mutant strains deficient in SPI1-T3SS show only minor defects in eliciting typhoid fever-like diseases in a murine model, indicating alternative routes of entry. Second, a role of the SPI1-T3SS in eliciting intestinal inflammation has been reported that mainly affects the competing intestinal flora and promotes Salmonella growth in the intestine.[@R33]

![**Figure 2.** Interference of Salmonella with DCs functions. (**A**) Salmonella breaches the intestinal barrier using different mechanisms. The epithelium covering the Peyer's Patches (PP) can be overcome through (1) uptake via M cells in PP, (2) invasion of enterocytes of the intestinal epithelium and (3) capture by DCs that sample antigens in the intestinal lumen with their dendrites which are extended through the epithelial cell layer. Once Salmonella has overcome the intestinal barrier, it encounters DCs, which internalize the bacteria through phagocytosis. (**B**) Upon phagocytosis, Salmonella induces the upregulation of CCR7 receptors on the DC surface, resulting in DC migration from PP to secondary lymphoid tissues such as mesenteric lymph nodes (MLN) and spleen, which both contain a high concentration of chemokines CCL19 and CCL21. At the same time, by means of specific effector proteins injected through the SPI2-encoded T3SS, Salmonella rapidly modifies the phagosome to form a unique Salmonella-containing vacuole (SCV) to segregate itself from the endolysosomal system, and so prevents bacterial degradation by the host cell. Additionally, by means of the SPI2-T3SS, Salmonella inhibits the presentation of antigens on the DC surface. (**C**) Arrived at MLN, infected DCs are reduced or unable in stimulation of T cells since they lack the presentation of antigens on the surface. Additionally, Salmonella disseminates into secondary lymphoid tissues, suggesting a role for DCs as vehicles exploited by Salmonella for systemic dissemination.](viru-3-660-g2){#F2}

As various other pathogens, Salmonella is able to penetrate the intestinal epithelium via M cells.[@R34] M cells are a cell population residing in the follicle-associated epithelium (FAE) overlaying Peyer's patches (PP), which sample antigens of the intestinal content and its normal flora. The M cells help transport the bacteria across the epithelial barrier, via transcytosis, into the subepithelial dome (SED), where they are delivered to the underlying lymphoid cells such as DCs in the lamina propria (LP) or Peyer's patches (PP).

Moreover, Salmonella can be captured directly from the intestinal lumen by DCs. These DCs, located in the LP or the PP, sample intestinal antigens with their dendrites extending through the epithelial monolayers and interact with the intestinal microbiota in a CX~3~CR1-dependent process.[@R35] Yet, this DC subset has been recently found to be a non-migratory, gut resident population[@R36] and is therefore very unlikely to participate in bacterial dissemination beyond the mucosa. However, the subset might serve as a first line barrier against invading pathogens by modulating immune responses directly in the mucosa.

DCs as "Trojan horses" for pathogen dissemination
-------------------------------------------------

Once Salmonella has overcome the intestinal barrier and is captured by DCs in PP or LP, DCs have to interact and trigger the activation of specific T lymphocytes. It was shown by Allenspach et al.[@R37] that antigen processing and presentation by both migratory and lymphoid-resident DCs is essential for the antigen-specific activation of T cells and to subsequently initiate adaptive immune responses. PP-resident CCR6^+^ DCs, recruited into the dome upon invasion of the FAE by pathogens, have been found to be responsible for rapid local activation of pathogen specific T cells.[@R38] This serves as a requisite step in T cell activation, since its function is to prime the T cells for subsequent interactions with migratory DCs.[@R37] CCR6^+^ DCs are not found in the LP.

Migratory DCs, on the other hand, do not induce local T cell activation. Upon pathogen recognition by pattern recognition receptors (PRRs), migratory DCs are activated to increase the expression of the CCR7, a receptor for the chemokines CCL19 and CCL21.[@R39] Up- and downregulation of this receptor enables DC migration along chemotactic gradients from the site of infection to lymphoid tissues such as lymph nodes and spleen.[@R40] Once in the lymph node, DCs that captured antigen will induce T cell differentiation by presenting pathogen-derived antigens and secreting cytokines, but this generic DC function is affected if virulent Salmonella is phagocytosed.

Salmonella-infected DCs from intestine, both LP- and PP-derived, migrate via afferent lymphatics to mesenteric lymph nodes (MLN) from where Salmonella can further disseminate to various organs. The route and vehicles for systemic spread are not fully understood. In order to extend the infection beyond the intestinal mucosa, Salmonella has to possess various factors allowing not only survival within macrophages, but also interference with the immunostimulatory capacity of DCs. This trait was found to be regulated by the multi-factorial PhoPQ regulatory system, which is responsible for the expression of proteins required for virulence and macrophage survival.[@R41] In this regard, the *phoP* locus has been shown to influence the processing of bacterial antigens by activated DCs.[@R42]

However, besides specific protection strategies to ensure bacterial survival, Salmonella needs to have transport for its dissemination. In this regard, Cheminay et al.[@R40] discovered that Salmonella may exploit DC migration by showing that Salmonella induced upregulation of CCR7 expression, results in migration of DCs toward increased CCL19 and CCL211 concentrations in secondary lymphoid tissues. However, this did not require viable nor internalized Salmonella. Additionally, the bacteria co-localized with only one third of the recruited DCs.[@R40] These data combined with the discovery that intracellular Salmonella is able to interfere with antigen presentation by DCs (see below), strongly implies that Salmonella uses DCs as camouflaged vehicles for its dissemination, in other words, as "Trojan horses" for systemic dissemination ([Fig. 2](#F2){ref-type="fig"}).

Recent research reveals a novel mechanism by which intracellular Salmonella interferes with host cell migration of phagocytes itself to evade bacterial clearance, whereby it is able to maintain a long-term chronic systemic infection in mice.[@R43] In this, the SPI2-T3SS effector protein SseI (alternative designation SrfH) plays two distinct roles: (1) regulating cell adherence during early stages of infection, causing early escape of Salmonella from the GI tract,[@R44] and (2) specific binding of the cell migration regulator, IQGAP1, during later stages, thereby blocking directed macrophage migration.[@R43] Interference with DC migration by SseI was found to correlate with reduced capacity of the host to clear Salmonella from systemic sites of infection.[@R43]

Not only Salmonella, but also *Mycobacterium tuberculosis*,[@R45] pathogens associated with ileal Crohn disease and even viruses like HIV[@R46] use specialized mechanisms to interfere with, or exploit host cell migration to prevent the initiation of adaptive immune responses and to further their dissemination. In Crohn tissue, an increased recruitment and accumulation of immature CD83^+^ DCs was observed in SED after bacterial internalization.[@R47] The pathogen is able to downregulate CCR7 expression, confiscating the DC ability to migrate to secondary lymph node tissue, and thus prevent T cell stimulation. In the case of HIV-1, the virus exploits DC migration to aid the establishment and dissemination of infection by binding DC-SIGN on the surface of immature DCs via the glycoprotein gp120, and hence initiates maturation.[@R46] In this way, DCs carry HIV-1 to the T cell compartment in lymphoid tissues and promotes *trans*-infection of T cells in the absence of viral replication in the DCs themselves.

So, although DCs play an important role in the fight against pathogenic infections by initiating adaptive immunity, pathogens themselves, including Salmonella, pathogens causing Crohn disease and HIV-1, have developed mechanisms which enable interference with, or exploitation of DC migration. This way, pathogens are able to facilitate dissemination within the host and circumvent immune responses, through inhibition of T cell stimulation.

The Intracellular Habitat of Salmonella in DCs
==============================================

Previous studies have indicated that the intracellular fate of Salmonella in DCs differs from that in macrophages.[@R48]^-^[@R50] Studies using a DC-like cell line indicated that the pathogen-containing vacuole in DCs lacks the late endosomal/lysosomal membrane marker LAMP1;[@R48] however, work with murine bone-marrow derived DCs indicated LAMP1-positive SCV.[@R50]

Compared with macrophages where the pH 5.0 is reached shortly after phagocytosis, phagosome acidification in DCs is delayed (reviewed in ref. [@R30]). The maintenance of a slightly alkaline pH was shown to be important to prevent destruction of potential peptides for antigen presentation and recognition by T cells.[@R51] The NADPH oxidase or NOX2 is in charge of producing oxygen radicals and controlling phagosomal pH. The absence of NOX2 in DCs led to increased antigen degradation, resulting in impaired "cross-presentation" of phagocytosed antigens to CD8^+^ T cells and subsequently, decreased T cell activation.[@R51]

Although both the SPI2-T3SS and PhoP/Q regulatory system are important for intracellular survival and replication in macrophages, both virulence factors are not essential for entry and survival of Salmonella in DCs.[@R49]^,^[@R50] A further disparity between fates of Salmonella within macrophages and DCs is the intracellular proliferation. Inside murine macrophage cell line cells, replication initiates after an initial lag period of 3--4 h after internalization. The function of the SPI2-T3SS and its translocated effector proteins is required for intracellular replication. In contrast, in murine bone-marrow derived DCs, Salmonella is able to survive, but does not replicate.[@R50] Although the SPI2-T3SS is not essential for Salmonella survival in DCs, it does influence the maturation of the SCV.[@R50] This indicates that Salmonella is able to modify normal cellular processes in DCs. In search of factors required for the survival in DCs, Zenk et al.[@R52] observed that de novo protein biosynthesis by Salmonella inside DCs is not required, but that the O-antigen of the LPS appears be to a key factor for bacterial survival.

Interference of Salmonella with DC Functions
============================================

The capability of Salmonella to cause systemic diseases relies on the ability to survive and replicate inside the host cell.[@R53]^,^[@R54] In addition, to achieve prolonged systemic persistence, Salmonella has developed mechanisms to alter normal host-cell functions by which it can evade host immune responses and subsequently avoid degradation. The SPI2-T3SS is activated upon host-cell invasion, and besides the modification and maintenance of the SCV, it has a key role in the escape of anti-microbial activities in macrophages.

Bueno et al.[@R55] have shown that, besides inducing phagocytosis in non-phagocytic cells, the SPI-1 is able to control the number of bacteria that enters DCs. Internalization via FcγRs receptors, accomplished by coating bacteria with Salmonella-specific IgG, has been shown to strongly enhance the efficiency of Ag uptake.[@R56] Here, DCs use a novel, PI3K/actin cytoskeleton/dynamin/Fcγ-receptor-independent mechanism to engulf IgG-coated Salmonella that remains yet to be elucidated.[@R57]

Communication between host cells at the side of bacterial infection and cells that have to be recruited from the circulation is essential to combat pathogens. In response to Salmonella infection DCs produce cytokines which serve as messengers to activate resting immune cells, like natural killer (NK) cells, granulocytes, macrophages and T cells.[@R58]^,^[@R59] Uchiya et al.[@R60] have shown three different, SPI2-dependent mechanisms for Salmonella to interfere with cytokine signaling, leading to the deactivation of macrophages: (1) through upregulation of interleukins, (2) through induction of the extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathway, leading to the expression of cyclooxygenase (COX) 2, and subsequently resulting in an increase in PGE2 and PGI2 production by macrophages[@R61] and (3) through upregulation of SOCS-3, a protein from the suppressor of cytokine signaling (SOCS) family, which negatively regulate the Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling pathway, and thereby inhibit cytokine signaling.[@R62] These observations were made for interaction of Salmonella with macrophages, and it has to be shown if similar interference occurs for Salmonella-DC interaction.

The most studied evasion strategy of Salmonella is its ability to avoid initiation of adaptive immunity. In vitro experiments have shown that Salmonella is able to inhibit T-cell activation by interfering with the presentation of antigens on the DC surface. Since DCs are important APC linking innate and adaptive immunity, interfering with their capacity to stimulate naïve T cells may allow pathogens evading adaptive immunity. Such interference would promote pathogen survival and dissemination, i.e., crucial events in Salmonella pathogenesis. Cheminay et al.[@R63] showed that intracellular Salmonella causes, in a SPI2-dependent manner, the alteration of MHC-II-dependent antigen-presentation by DCs. Additionally, the SPI2-T3SS in combination with the induced production of NO synthase by DCs, was found to suppress Ag-dependent T cell proliferation. The suggested mechanism for the escape of Ag presentation is by the inhibition of lysosomal degradation;[@R56]^,^[@R64] however, the exact mechanism remains unknown. The PhoP/PhoQ regulatory system, which controls the synthesis of many Salmonella proteins required for virulence and survival,[@R41] appears to play an important role in this escape mechanism, since Salmonella strains with mutations at the *phoP/Q* locus have been shown to fail to escape from lysososmal degradation and subsequently Ag processing and presentation.[@R49] Inhibition of lysososmal degradation can be overcome by, again, targeting Salmonella to FcγRs receptors on the DC surface.[@R56] Here, the entry route of Salmonella into the host cell appears to affect the initial phase of maturation of the SCV and its ability to avoid lysosomal degradation ([Fig. 3](#F3){ref-type="fig"}). Subsequent work identified a subset of SPI2-T3SS effectors that are required for the inhibition of MHC-II-dependent antigen presentation in DCs.[@R65] The effector proteins SifA, SspH2, SlrP, PipB2 and SopD2 showed strong and SseF and SseG moderate contribution to suppression of Ag-dependent T-cell stimulation by Salmonella-infected DCs. Additionally, Salmonella can control the expression of MHC II on the DC surface through polyubiquitination, which subsequently may reduce the ability of DCs to present antigen to CD4 T cells.[@R66]

![**Figure 3.** Manipulation of DC functions by intracellular Salmonella. Upon internalization into DCs, Salmonella remains in a membrane-bound compartment or SCV. The subsequent events of SCV biogenesis in DCs are not fully understood; however, fusion of lysosomal compartments with the SCV and killing of the bacterial is delayed or blocked. By functions of SPI2-T3SS effector proteins, intracellular Salmonella interferes with antigen processing and presentation. This in turn leads to a reduced stimulation of T cells and adaptive immune defense against Salmonella. Bacterial manipulation of DC function is an important factor for system spread and persistence of Salmonella. The exact mechanisms for the inhibition of Ag presentation, possible bacterial escape from the DCs, and the subsequent dissemination remain to be elucidated.](viru-3-660-g3){#F3}

The impairment of DC functions by the activity of SPI2 gene products is crucial for Salmonella pathogenesis. However, the ability of Salmonella serovars to survive within DCs is host specific and is characterized by their capacity to interfere with the function of DCs and avoid host adaptive immune responses.[@R54] So is *S*. *enterica* ser Typhi specific for humans and primates and fails to cause systemic infection in mice and most other species, whereas *S*. *enterica* ser Typhimurium and Enteritidis have a broader host specificity and different disease outcome. Based on previous studies, the host's immune response was suggested to be a key component in Salmonella host restriction.[@R54]^,^[@R67] These observations suggest a role for DCs as cellular components influencing pathogen-host specificity. However, the exact molecular reasons for these differences are only partially understood and are probably multi-factorial.

Conclusions and Future Perspectives
===================================

DCs have the unique ability to link innate and adaptive immunity, which makes them attractive targets for manipulation by intracellular pathogens like Salmonella. Alteration of host cell functions allows Salmonella to evade immune responses, survive in the intracellular space and subsequently disseminate from the site of infection to internal tissues to cause systemic infections ([Fig. 2](#F2){ref-type="fig"}).

Over the last two decades, several virulence mechanisms involved in the interaction between Salmonella and its host cells have been identified. Since most of the studies have been focused on the interaction with macrophages and epithelial cells, only limited information is available on the exact interface between Salmonella and DCs. The SCV within DCs, for example, has been reported to be unique compartment distinct from that in macrophages, since it lacks specific membrane markers[@R48] and does neither allow intracellular proliferation nor efficient killing of Salmonella.[@R50]^,^[@R52] However, other phenotypes such as the induction of dynamic tubular membrane compartments appear shared in macrophages and DCs.[@R68] However, it remains unclear why the intracellular compartment of Salmonella in DCs differs from that in macrophages. Is there a specific set of Salmonella virulence factors for the modification of the SCV in DCs? How does Salmonella benefit from this difference? Despite the limited data available so far, in vitro experiments have revealed that the ability to interfere with the immune stimulatory capacity of DCs is most likely from high significance for Salmonella to be able to cause systemic disease in the host. By inhibiting processing and presentation of bacterial Ag on the DC surface, T cell activation and thus the initiation of adaptive immunity is prevented. Additionally this could allow Salmonella to exploit DCs as reservoirs and vehicles, for its dissemination to secondary lymphoid tissues and beyond. Nevertheless, numerous aspects remain unclear even in this regard ([Fig. 3](#F3){ref-type="fig"}): What is the exact mechanism for interference with Ag presentation and how does Salmonella eventually escape from the DCs?

However, in contrast to in vitro experiments, in vivo studies have documented robust CD4 T cell activation within a few hours of oral Salmonella infection. Recent work has demonstrated that Salmonella is able to actively induce apoptosis of Ag-specific CD4 T cells in a SPI2-dependent manner.[@R69] This suggests that the inhibitory effect of SPI2 effectors may inhibit survival of Salmonella-specific T cells, rather than inhibit initial activation, in vivo. While a difference between in vitro and in vivo findings complicates the picture somewhat, it still supports the overall idea that SPI2 effectors are actively involved in the inhibition of T cell responses to Salmonella. Nevertheless, this emphasizes the importance of in vivo experiments to complement in vitro experiments. Additionally, host specificity of Salmonella is a complex phenomenon that remains yet unclear. Despite the fact that *S. enterica* subspecies share more than 90% for their genomes, these bacteria show differential abilities to survive and proliferate within DCs in line with their ability to avoid initiation of adaptive immunity. However, the genetic differences or other molecular reasons that could account for these variations are only partially understood and are most likely multi-factorial.

A major limitation for the research of Salmonella-DC interaction is the lack of an immortalized cell line that exhibits DC functions, and the heterogeneity of DCs obtained by differentiation from primary precursor cells. Furthermore, the correlation of in vitro studies for Salmonella-DC interaction to in vivo studies is difficult. A main obstacle is the identification and tracking of Salmonella-infected DCs in the setting of an animal infection. However, a number of recent studies in this direction[@R35]^,^[@R70]^,^[@R71] indicate that new imaging techniques and use of transgenic animals may enable to track Salmonella-DC interaction in vivo with high temporal and spatial resolution.

Besides being an attractive target for intracellular pathogens, DCs are being considered as valuable targets in the design of vaccines.[@R72] For example, by enhancing immunity using live attenuated vaccines based on Salmonella mutant strains, Salmonella infections can be prevented and treated.[@R73] Since these mutant strains would be unable to induce an inflammatory reaction, survive within macrophages and interfere with host cell functions, but would still be taken up by DCs in the PP, processing and presentation of Salmonella*-*derived antigens would occur more efficiently, even as the stimulation of naïve T cells. On the other hand, the targeting of genetically engineered microbial proteins to DCs would be an alternative strategy to boost immunogenesis.[@R72] Here, vaccine antigens would be directly delivered to specific receptors on the DC surface, accompanied by pathogen specific DC maturation and resulting in a \> 100-fold enhancement of presentation efficiency. Although both strategies seem promising for the treatment and prevention of infections, still major gaps in the knowledge exits before this science can be taken into medicine and to solve this, more in vivo, but also patient-based research, is of great importance.

Further research is required to address the open questions concerning the interaction of Salmonella with DCs. Complete understanding of the interface between Salmonella and DCs would eventually provide valuable information for the development of new strategies to prevent systemic infection caused by this pathogen.
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